Income Statement 3billion, Inc.

Stocks

A394800

KR7394800007

Biotechnology & Medical Research

End-of-day quote Korea S.E. 2026-09-23			5-day change	1st Jan Change
5,800.00 ^KRW	+23.27%		+34.57%	-68.18%

06-01	3billion Launches 3B-NEO, Genomic Newborn Screening Service Covering 595 Clinically Actionable Genetic Conditions	CI
05-12	3billion, Inc. announced that it has received KRW 29.9999999 billion in funding from Meritz Securities Co., Ltd., Wonik Investment Partners Co., Ltd.	CI

fa6e09dc4a9f5da3347640949cda990.Phme3aZLqyqRFvYnIkGDgDSH_etQwPsVXDSjf5F9uak.e2zS7vwF-UmpX5hFRBbF5UHBq5sbipZ9KmbuKucu4Zx2Y9aR4wLZZ8BDgQ

Published financial data: 3BILLION, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020 (KRW)	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)
Revenues	25.08M	551M	828M	2.73B	5.77B
Total Revenues	25.08M	551M	828M	2.73B	5.77B
Gross Profit	25.08M	551M	828M	2.73B	5.77B
Selling General & Admin Expenses, Total	1.68B	4.47B	5.71B	6.11B	8.25B
Provision for Bad Debts	-	-	-	29.55M	18.04M
R&D Expenses	2.16B	2.48B	2.99B	3.52B	3.66B
Depreciation & Amortization - (IS)	152M	297M	352M	1.39B	1.21B
Amortization of Goodwill and Intangible Assets - (IS)	-	-	-	36.38M	42.88M
Other Operating Expenses, Total	3.99B	7.25B	9.05B	11.08B	13.19B
Operating Income	-3.97B	-6.7B	-8.22B	-8.35B	-7.42B
Interest Expense, Total	-21.07M	-30.61M	-25.94M	-63.41M	-24.58M
Interest And Investment Income	38.15M	128M	391M	623M	351M
Net Interest Expenses	17.08M	97.64M	365M	559M	326M
Currency Exchange Gains (Loss)	-37K	2.17M	6.28M	-10.73M	111M
Other Non Operating Income (Expenses)	-14.54B	-52.51B	4.71B	2.71B	-49.64M
EBT, Excl. Unusual Items	-18.49B	-59.1B	-3.14B	-5.09B	-7.03B
Gain (Loss) On Sale Of Assets	-	-	-	-	460M
EBT, Incl. Unusual Items	-18.49B	-59.1B	-3.14B	-5.09B	-6.57B
Earnings From Continuing Operations	-18.49B	-59.1B	-3.14B	-5.09B	-6.57B
Net Income to Company	-18.49B	-59.1B	-3.14B	-5.09B	-6.57B
Net Income - (IS)	-18.49B	-59.1B	-3.14B	-5.09B	-6.57B
Net Income to Common Incl Extra Items	-18.49B	-59.1B	-3.14B	-5.09B	-6.57B
Net Income to Common Excl. Extra Items	-18.49B	-59.1B	-3.14B	-5.09B	-6.57B
Per Share Items
Net EPS - Basic	-	-	-	-	-234.02
Basic EPS - Continuing Operations	-	-	-	-	-234.02
Basic Weighted Average Shares Outstanding	-	-	-	-	28.08M
Net EPS - Diluted	-	-	-	-	-234.02
Diluted EPS - Continuing Operations	-	-	-	-	-234.02
Diluted Weighted Average Shares Outstanding	-	-	-	-	28.08M
Normalized Basic EPS	-	-	-	-	-156.5
Normalized Diluted EPS	-	-	-	-	-156.5
Supplemental Items
EBITDA	-3.48B	-5.94B	-7.27B	-6.93B	-5.74B
EBITA	-3.97B	-6.69B	-8.2B	-8.32B	-7.38B
EBIT	-3.97B	-6.7B	-8.22B	-8.35B	-7.42B
Normalized Net Income	-11.56B	-36.94B	-1.97B	-3.18B	-4.39B
Supplemental Operating Expense Items
Selling and Marketing Expenses	217M	772M	900M	997M	1.61B
General and Administrative Expenses	94.74M	179M	193M	291M	319M
Research And Development Expense From Footnotes	2.16B	2.48B	2.99B	3.52B	3.66B
Stock-Based Comp., SG&A Exp. (Total)	172M	344M	446M	491M	386M
Total Stock-Based Compensation	172M	344M	446M	491M	386M

Fiscal Period: December	2020 (KRW)	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)
Assets
Cash And Equivalents	14.93B	4.72B	7.02B	2.7B	11.66B
Short Term Investments	-	12B	15.75B	14.04B	12.68B
Trading Asset Securities, Total	65.32M	-	-	-	-
Total Cash And Short Term Investments	15B	16.72B	22.77B	16.73B	24.35B
Accounts Receivable, Total	6.78M	61.26M	50.3M	148M	425M
Other Receivables	-	229M	481M	396M	232M
Total Receivables	6.78M	290M	531M	543M	658M
Inventory	141M	304M	410M	329M	222M
Prepaid Expenses	-	66.71M	62.45M	161M	172M
Other Current Assets, Total	17.72M	51.95M	143M	393M	721M
Total Current Assets	15.16B	17.44B	23.92B	18.16B	26.12B
Gross Property Plant And Equipment	2.45B	3.57B	4.28B	5.61B	4.17B
Accumulated Depreciation	-338M	-797M	-1.37B	-2.02B	-1.38B
Net Property Plant And Equipment	2.11B	2.77B	2.91B	3.59B	2.79B
Long-term Investments	176M	300	390	-210	-
Other Intangibles, Total	5.44M	81.36M	140M	131M	123M
Other Long-Term Assets, Total	-	302M	692M	975M	1.19B
Total Assets	17.46B	20.59B	27.66B	22.86B	30.22B
Liabilities
Accounts Payable, Total	6.26M	9.48M	10.99M	309M	176M
Accrued Expenses, Total	-	133M	174M	128M	156M
Short-term Borrowings	30.73M	-	-	-	-
Current Portion of Leases	143M	289M	712M	700M	59.21M
Other Current Liabilities	36.18B	739M	9.62B	9.71B	1.48B
Total Current Liabilities	36.36B	1.17B	10.51B	10.85B	1.87B
Long-Term Leases	411M	567M	704M	56.41M	-
Pension & Other Post Retirement Benefits	68.79M	10.43M	-	-	-
Other Non Current Liabilities	63.26M	129M	130M	165M	71.8M
Total Liabilities	36.9B	1.88B	11.35B	11.07B	1.94B
Common Stock, Total	1.21B	2.55B	2.58B	2.59B	3.17B
Additional Paid In Capital	2.44B	97.97B	98.24B	98.53B	121B
Retained Earnings	-22.54B	-81.6B	-84.61B	-89.74B	-96.35B
Comprehensive Income and Other	-556M	-212M	104M	405M	94.58M
Total Common Equity	-19.45B	18.71B	16.31B	11.79B	28.27B
Total Equity	-19.45B	18.71B	16.31B	11.79B	28.27B
Total Liabilities And Equity	17.46B	20.59B	27.66B	22.86B	30.22B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	-	-	-	-	31.68M
ECS Total Common Shares Outstanding	-	-	-	-	31.68M
Book Value / Share	-	-	-	-	892.27
Tangible Book Value	-19.45B	18.63B	16.17B	11.66B	28.15B
Tangible Book Value Per Share	-	-	-	-	888.39
Total Debt	584M	856M	1.42B	756M	59.21M
Net Debt	-14.41B	-15.87B	-21.35B	-15.98B	-24.29B
Inventories - Raw Materials, Total	-	-	-	329M	222M
Inventories - Others	141M	304M	410M	400	150
Machinery, Total	1.63B	2.17B	2.35B	2.61B	3.99B
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	3.58M	4.23M

Fiscal Period: December	2020 (KRW)	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)
Net Income	-18.49B	-59.1B	-3.14B	-5.09B	-6.57B
Depreciation & Amortization - CF	484M	756M	927M	1.39B	1.64B
Amortization of Goodwill and Intangible Assets - (CF)	772K	4.67M	23.56M	36.38M	42.88M
Depreciation & Amortization, Total	484M	761M	950M	1.43B	1.68B
(Gain) Loss From Sale Of Asset	-	-	-	-	-460M
Stock-Based Compensation (CF)	172M	344M	446M	491M	386M
Provision and Write-off of Bad Debts	-	-	-	29.55M	18.04M
Other Operating Activities, Total	15.22B	53.48B	-3.91B	-1.8B	1.12B
Change In Accounts Receivable	-6.78M	-54.51M	10.97M	-102M	-276M
Change In Inventories	-141M	-163M	-106M	81.43M	107M
Change In Accounts Payable	5.84M	3.21M	1.51M	298M	-133M
Change in Other Net Operating Assets	62.68M	99.75M	-662M	-203M	21.08M
Cash from Operations	-2.7B	-4.63B	-6.41B	-4.87B	-4.1B
Capital Expenditure	-1.8B	-587M	-209M	-234M	-2.78B
Sale of Property, Plant, and Equipment	-	-	-	-	677M
Sale (Purchase) of Intangible assets	-5.08M	-87.79M	-54.92M	-12.58M	-16.19M
Investment in Marketable and Equity Securities, Total	-	-11.96B	-3.75B	1.71B	2.24B
Other Investing Activities, Total	8.3M	-160M	-284M	-284M	-1.06B
Cash from Investing	-1.8B	-12.8B	-4.3B	1.18B	-944M
Long-Term Debt Repaid, Total	-143M	-271M	-304M	-743M	-715M
Total Debt Repaid	-143M	-271M	-304M	-743M	-715M
Issuance of Common Stock	2.5B	-	165M	113M	15.32B
Issuance of Preferred Stock	4B	7.5B	13.15B	-	-
Other Financing Activities, Total	-21.27M	-8.44M	-8.28M	-	-593M
Cash from Financing	6.33B	7.22B	13B	-630M	14.01B
Foreign Exchange Rate Adjustments	-	1.77M	6.96M	-439K	4.35M
Net Change in Cash	1.83B	-10.21B	2.3B	-4.32B	8.97B
Supplemental Items
Cash Income Tax Paid (Refund)	2.15M	295K	25.26M	48.54M	8.77M
Levered Free Cash Flow	15.5B	-39.6B	4.46B	-3.52B	-14.06B
Unlevered Free Cash Flow	15.52B	-39.58B	4.48B	-3.48B	-14.05B
Change In Net Working Capital	-19.15B	35.82B	-8.49B	-70.59M	8.68B
Net Debt Issued / Repaid	-143M	-271M	-304M	-743M	-715M

Fiscal Period: December	2020 (KRW)	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)
Profitability
Return on Assets	-15.6	-22.01	-21.31	-20.67	-17.47
Return on Total Capital	22.76	-1.24K	-27.56	-34.49	-22.69
Return On Equity %	160.37	16.12K	-17.96	-36.24	-32.81
Return on Common Equity	160.37	16.12K	-17.96	-36.24	-32.81
Margin Analysis
Gross Profit Margin %	100	100	100	100	100
SG&A Margin	6.68K	811.53	688.95	223.64	142.97
EBITDA Margin %	-13.88K	-1.08K	-877.97	-253.68	-99.36
EBITA Margin %	-15.81K	-1.22K	-989.84	-304.57	-127.79
EBIT Margin %	-15.82K	-1.22K	-992.68	-305.91	-128.53
Income From Continuing Operations Margin %	-73.73K	-10.73K	-379.6	-186.5	-113.85
Net Income Margin %	-73.73K	-10.73K	-379.6	-186.5	-113.85
Net Avail. For Common Margin %	-73.73K	-10.73K	-379.6	-186.5	-113.85
Normalized Net Income Margin	-46.08K	-6.71K	-237.25	-116.56	-76.14
Levered Free Cash Flow Margin	61.8K	-7.19K	538.54	-128.87	-243.64
Unlevered Free Cash Flow Margin	61.86K	-7.19K	540.49	-127.42	-243.37
Asset Turnover
Asset Turnover	0	0.03	0.03	0.11	0.22
Fixed Assets Turnover	0.02	0.23	0.29	0.84	1.81
Receivables Turnover (Average Receivables)	-	16.19	14.85	27.59	20.14
Short Term Liquidity
Current Ratio	0.42	14.9	2.28	1.67	13.94
Quick Ratio	0.41	14.54	2.22	1.59	13.35
Operating Cash Flow to Current Liabilities	-0.07	-3.96	-0.61	-0.45	-2.19
Days Sales Outstanding (Average Receivables)	-	22.55	24.58	13.23	18.17
Long Term Solvency
Total Debt/Equity	-3.01	4.58	8.68	6.42	0.21
Total Debt / Total Capital	-3.1	4.38	7.99	6.03	0.21
LT Debt/Equity	-2.11	3.03	4.32	0.48	-
Long-Term Debt / Total Capital	-2.18	2.9	3.97	0.45	-
Total Liabilities / Total Assets	211.38	9.11	41.02	48.44	6.44
EBIT / Interest Expense	-188.28	-218.81	-317.1	-131.72	-301.77
EBITDA / Interest Expense	-165.29	-193.97	-280.45	-109.23	-233.28
(EBITDA - Capex) / Interest Expense	-250.89	-213.15	-288.53	-112.92	-346.43
Total Debt / EBITDA	-0.17	-0.14	-0.19	-0.11	-0.01
Net Debt / EBITDA	4.14	2.67	2.94	2.31	4.23
Total Debt / (EBITDA - Capex)	-0.11	-0.13	-0.19	-0.11	-0.01
Net Debt / (EBITDA - Capex)	2.73	2.43	2.85	2.23	2.85
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-17.12	2.1K	50.45	229.57	111.41
Gross Profit, 1 Yr. Growth %	-17.12	2.1K	50.45	229.57	111.41
EBITDA, 1 Yr. Growth %	173.04	70.49	22.5	-4.77	-17.2
EBITA, 1 Yr. Growth %	208.15	68.75	22.51	1.41	-11.3
EBIT, 1 Yr. Growth %	208.18	68.84	22.78	1.56	-11.17
Earnings From Cont. Operations, 1 Yr. Growth %	411.71	219.58	-94.68	61.92	29.06
Net Income, 1 Yr. Growth %	411.71	219.58	-94.68	61.92	29.06
Normalized Net Income, 1 Yr. Growth %	411.71	219.58	-94.68	61.92	38.09
Diluted EPS Before Extra, 1 Yr. Growth %	-	-	-	-	16.43
Accounts Receivable, 1 Yr. Growth %	-	804.01	-17.9	193.57	188.15
Inventory, 1 Yr. Growth %	-	115.29	35.04	-19.86	-32.49
Net Property, Plant and Equip., 1 Yr. Growth %	166.19	31.03	5.09	23.42	-22.48
Total Assets, 1 Yr. Growth %	21.76	17.93	34.35	-17.36	32.18
Tangible Book Value, 1 Yr. Growth %	437.31	-195.78	-13.19	-27.93	141.5
Common Equity, 1 Yr. Growth %	437.37	-196.23	-12.82	-27.75	139.86
Cash From Operations, 1 Yr. Growth %	148.04	71.46	38.47	-24	-15.83
Capital Expenditures, 1 Yr. Growth %	4.47K	-67.45	-64.34	11.71	1.09K
Levered Free Cash Flow, 1 Yr. Growth %	-	-355.98	-111.27	-178.87	299.67
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-355.64	-111.31	-177.69	303.78
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	326.55	474.7	122.67	163.96
Gross Profit, 2 Yr. CAGR %	-	326.55	474.7	122.67	163.96
EBITDA, 2 Yr. CAGR %	-	115.76	44.52	8.01	-11.2
EBITA, 2 Yr. CAGR %	-	128.04	43.79	11.46	-5.16
EBIT, 2 Yr. CAGR %	-	128.11	43.98	11.67	-5.02
Earnings From Cont. Operations, 2 Yr. CAGR %	-	304.4	-58.76	-70.65	44.56
Net Income, 2 Yr. CAGR %	-	304.4	-58.76	-70.65	44.56
Normalized Net Income, 2 Yr. CAGR %	-	304.4	-58.76	-70.65	49.53
Accounts Receivable, 2 Yr. CAGR %	-	-	172.43	55.25	190.85
Inventory, 2 Yr. CAGR %	-	-	70.51	4.03	-26.44
Net Property, Plant and Equip., 2 Yr. CAGR %	-	86.76	17.35	13.88	-2.18
Total Assets, 2 Yr. CAGR %	-	19.83	25.87	5.37	4.52
Tangible Book Value, 2 Yr. CAGR %	-	126.86	-8.82	-20.91	31.92
Common Equity, 2 Yr. CAGR %	-	127.4	-8.41	-20.64	31.64
Cash From Operations, 2 Yr. CAGR %	-	106.22	54.08	2.58	-20.02
Capital Expenditures, 2 Yr. CAGR %	-	285.53	-65.93	-36.88	264.51
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-46.29	-70.19	77.54
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-46.22	-70.35	77.12
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	201.38	377.46	118.85
Gross Profit, 3 Yr. CAGR %	-	-	201.38	377.46	118.85
EBITDA, 3 Yr. CAGR %	-	-	78.66	25.76	-1.15
EBITA, 3 Yr. CAGR %	-	-	85.38	27.99	3.29
EBIT, 3 Yr. CAGR %	-	-	85.55	28.17	3.47
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-4.53	-34.94	-51.91
Net Income, 3 Yr. CAGR %	-	-	-4.53	-34.94	-51.91
Normalized Net Income, 3 Yr. CAGR %	-	-	-4.53	-34.94	-50.82
Accounts Receivable, 3 Yr. CAGR %	-	-	-	179.3	90.79
Inventory, 3 Yr. CAGR %	-	-	-	32.57	-9.93
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	54.19	19.34	0.18
Total Assets, 3 Yr. CAGR %	-	-	24.49	9.4	13.64
Tangible Book Value, 3 Yr. CAGR %	-	-	64.7	-15.69	14.74
Common Equity, 3 Yr. CAGR %	-	-	65.19	-15.37	14.74
Cash From Operations, 3 Yr. CAGR %	-	-	80.58	21.74	-3.97
Capital Expenditures, 3 Yr. CAGR %	-	-	74.36	-49.38	67.96
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-38.96	-29.18
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-39.2	-29.2
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	185.81
Gross Profit, 5 Yr. CAGR %	-	-	-	-	185.81
EBITDA, 5 Yr. CAGR %	-	-	-	-	35.08
EBITA, 5 Yr. CAGR %	-	-	-	-	41.79
EBIT, 5 Yr. CAGR %	-	-	-	-	41.95
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	12.7
Net Income, 5 Yr. CAGR %	-	-	-	-	12.7
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	14.24
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	28.53
Total Assets, 5 Yr. CAGR %	-	-	-	-	16.08
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	50.71
Common Equity, 5 Yr. CAGR %	-	-	-	-	50.85
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	30.37
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	134.18